CSS LLC’s SpringWorks Therapeutics SWTX Stock Holding History

CSS LLC’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,000	Closed	-$141K	–	1181
2025 Q2	$141K	Buy	+3,000	New	+$133K	0.01%	795
2023 Q1	–	Sell	-65,200	Closed	-$1.7M	–	894
2022 Q4	$1.7M	Buy	+65,200	New	+$1.61M	0.1%	184
2022 Q2	–	Sell	-15,700	Closed	-$887K	–	1218
2022 Q1	$887K	Buy	+15,700	New	+$898K	0.03%	471

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CSS LLC's SWTX Position: Q3 2025 in Review

CSS LLC sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 10,000 shares — an estimated $470K sold.

CSS LLC first reported a position in SWTX in Q2 2022 and held it in 2 quarters. The position peaked at $470K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

CSS LLC reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
CSS LLC sold 10,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $470K.
CSS LLC first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 2 quarters.
CSS LLC's SpringWorks Therapeutics position peaked at $470K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on CSS LLC's 13F filing for Q3 2025, filed 13 Nov 2025.